Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Arvinas Holding Company, Llc (ARVN)  
$31.36 0.21 (0.67%) as of 4:30 Tue 5/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 68,788,000
Market Cap: 2.16(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $14.19 - $52.31
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Arvinas is a biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies to degrade disease-causing proteins. Co. is developing ARV-110, a proteolysis targeting chimeras (PROTAC) targeted protein degrader targeting the androgen receptor protein for the treatment of men with metastatic castration-resistant prostate cancer. Co. is also developing ARV-471, a PROTAC targeted protein degrader targeting the estrogen receptor protein, or ER, for the treatment of patients with locally advanced or metastatic ER positive / HER2 negative breast cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 10,298 10,298 11,622 21,554
Total Sell Value $484,521 $484,521 $516,810 $859,747
Total People Sold 4 4 4 4
Total Sell Transactions 4 4 5 9
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 174
  Page 2 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Morrison Briggs Director   –       •      –    2022-04-14 4 AS $65.24 $1,392,616 D/D (20,960) 19,976 -30%     
   Morrison Briggs Director   –       •      –    2022-04-14 4 OE $16.00 $259,008 D/D 16,188 40,936     -
   Taylor Ian Chief Scientific Officer   •       –      –    2022-03-31 4 GD $0.00 $0 D/D 3,000 80,962     -
   Cassidy Sean A Chief Financial Officer   •       –      –    2022-03-11 4 AS $70.00 $1,050,000 D/D (15,000) 161,447 -20%     
   Cassidy Sean A Chief Financial Officer   •       –      –    2022-03-11 4 OE $16.00 $240,000 D/D 15,000 176,447     -
   Houston John G President and CEO   •       •      –    2022-03-04 4 S $63.94 $385,175 D/D (6,024) 843,820 24%     
   Houston John G President and CEO   •       •      –    2022-03-04 4 OE $0.00 $0 D/D 17,511 849,844     -
   Cassidy Sean A Chief Financial Officer   •       –      –    2022-03-04 4 S $63.94 $101,856 D/D (1,593) 161,447 24%     
   Cassidy Sean A Chief Financial Officer   •       –      –    2022-03-04 4 OE $0.00 $0 D/D 4,791 163,040     -
   Taylor Ian Chief Scientific Officer   •       –      –    2022-03-04 4 S $63.94 $55,564 D/D (869) 83,962 24%     
   Taylor Ian Chief Scientific Officer   •       –      –    2022-03-04 4 OE $0.00 $0 D/D 2,686 84,831     -
   Taylor Ian Chief Scientific Officer   •       –      –    2022-03-01 4 OE $16.00 $56,000 D/D 3,500 82,145     -
   Taylor Ian Chief Scientific Officer   •       –      –    2022-02-15 4 AS $71.74 $1,460,316 D/D (20,000) 78,645 -38%     
   Taylor Ian Chief Scientific Officer   •       –      –    2022-02-15 4 OE $19.36 $387,200 D/D 20,000 98,645     -
   Morrison Briggs Director   –       •      –    2022-01-14 4 AS $64.33 $1,374,021 D/D (20,960) 24,748 -37%     
   Morrison Briggs Director   –       •      –    2022-01-14 4 OE $16.00 $259,008 D/D 16,188 45,708     -
   Peck Ronald Chief Medical Officer   •       –      –    2021-12-30 4 AS $80.35 $1,612,264 D/D (20,000) 5,402 -47%     
   Peck Ronald Chief Medical Officer   •       –      –    2021-12-30 4 OE $26.58 $830,600 D/D 20,000 25,402     -
   Cassidy Sean A Chief Financial Officer   •       –      –    2021-12-17 4 AS $70.00 $1,050,000 D/D (15,000) 158,249 -25%     
   Cassidy Sean A Chief Financial Officer   •       –      –    2021-12-17 4 OE $16.00 $240,000 D/D 15,000 173,249     -
   Ratcliffe Liam Director   –       •      –    2021-12-16 4 S $68.97 $5,944,418 I/I (85,705) 185,686 18%     
   Ratcliffe Liam Director   –       •      –    2021-12-15 4 S $65.74 $7,584,964 I/I (113,536) 271,391 17%     
   Ratcliffe Liam Director   –       •      –    2021-12-14 4 S $64.20 $10,303,999 I/I (156,464) 384,927 11%     
   Taylor Ian Chief Scientific Officer   •       –      –    2021-11-15 4 AS $83.07 $1,680,746 D/D (20,000) 78,645 -19%     
   Taylor Ian Chief Scientific Officer   •       –      –    2021-11-15 4 OE $16.00 $346,188 D/D 20,000 98,645     -
  174 Records found
  1  2  3  4  5  6  7   
  Page 2 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us